Applying extracellular vesicles based therapeutics in clinical trials – an ISEV position paper

微泡 细胞外小泡 良好制造规范 立场文件 欧洲联盟 靶向给药 医学 药品 生物 药理学 生物技术 业务 细胞生物学 小RNA 监管事务 病理 基因 经济政策 生物化学
作者
Thomas Lener,Mario Gimona,Ludwig Aigner,Verena Börger,Edit I. Buzás,Giovanni Camussi,Nathalie Chaput,Devasis Chatterjee,Felipe A. Court,Hernando Antonio Del Portillo,Lorraine O’Driscoll,Stefano Fais,Juan Manuel Falcón‐Pérez,Ursula Felderhoff‐Mueser,Lorenzo José Fraile,Yong Song Gho,André Görgens,Ramesh C. Gupta,An Hendrix,Dirk Matthias Hermann
出处
期刊:Journal of extracellular vesicles [Taylor & Francis]
卷期号:4 (1): 30087-30087 被引量:1767
标识
DOI:10.3402/jev.v4.30087
摘要

Extracellular vesicles (EVs), such as exosomes and microvesicles, are released by different cell types and participate in physiological and pathophysiological processes. EVs mediate intercellular communication as cell-derived extracellular signalling organelles that transmit specific information from their cell of origin to their target cells. As a result of these properties, EVs of defined cell types may serve as novel tools for various therapeutic approaches, including (a) anti-tumour therapy, (b) pathogen vaccination, (c) immune-modulatory and regenerative therapies and (d) drug delivery. The translation of EVs into clinical therapies requires the categorization of EV-based therapeutics in compliance with existing regulatory frameworks. As the classification defines subsequent requirements for manufacturing, quality control and clinical investigation, it is of major importance to define whether EVs are considered the active drug components or primarily serve as drug delivery vehicles. For an effective and particularly safe translation of EV-based therapies into clinical practice, a high level of cooperation between researchers, clinicians and competent authorities is essential. In this position statement, basic and clinical scientists, as members of the International Society for Extracellular Vesicles (ISEV) and of the European Cooperation in Science and Technology (COST) program of the European Union, namely European Network on Microvesicles and Exosomes in Health and Disease (ME-HaD), summarize recent developments and the current knowledge of EV-based therapies. Aspects of safety and regulatory requirements that must be considered for pharmaceutical manufacturing and clinical application are highlighted. Production and quality control processes are discussed. Strategies to promote the therapeutic application of EVs in future clinical studies are addressed.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
斯文败类的应助被眼角流星采纳,获得10
1秒前
经十路以东的应助被00hello00采纳,获得10
1秒前
1秒前
火山完成签到,获得积分10
2秒前
3秒前
3秒前
情怀的应助被闪耀的启明星采纳,获得10
3秒前
LYB完成签到 ,获得积分10
3秒前
4秒前
syvshc的应助被00hello00采纳,获得10
4秒前
呆桃完成签到 ,获得积分10
5秒前
王亚娟发布了新的文献求助10
6秒前
kookery完成签到,获得积分10
6秒前
贪玩丑发布了新的文献求助10
6秒前
拼搏惜金完成签到,获得积分10
6秒前
7秒前
刻苦的绿真完成签到 ,获得积分10
7秒前
科研通AI6.2的应助被茉莉花采纳,获得30
7秒前
Gu0F1发布了新的文献求助10
8秒前
wewe发布了新的文献求助10
8秒前
Yx发布了新的文献求助10
8秒前
Gustav_Lebon完成签到,获得积分10
8秒前
8秒前
袁帅完成签到 ,获得积分10
8秒前
9秒前
9秒前
Yifan完成签到,获得积分10
10秒前
yuan完成签到,获得积分10
10秒前
OK给青年才俊的求助进行了留言
10秒前
大个的应助被陈好采纳,获得30
11秒前
11秒前
12秒前
Mistyrain完成签到,获得积分10
13秒前
13秒前
Snowychen完成签到,获得积分10
14秒前
lyb完成签到 ,获得积分10
14秒前
双曲完成签到,获得积分10
14秒前
14秒前
14秒前
空集发布了新的文献求助10
15秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8194107
求助须知:如何正确求助?哪些是违规求助? 9580062
关于积分的说明 21869017
捐赠科研通 7793713
什么是DOI,文献DOI怎么找? 3437523
关于科研通互助平台的介绍 2560962
邀请新用户注册赠送积分活动 2484264